A new blood test has been developed that reads your entire virus history by analysing the antibodies in your bloodstream
Called VirScan it was developed by researchers at Harvard Medical School who insist that once it’s refined it will be cheap enough to mass produce. They estimate it will cost a mere £16 for the average person to take.
It works by analysing blood for antibodies for over 1,000 different strains of 206 human viruses simultaneously.
Because antibodies produced by the immune system to fight viruses stay in the blood stream for many years, the test can produce an accurate history of infections.
Up until now, most tests have revolved around looking for just a single virus. But the brains behind VirScan say it can process 100 samples in two to three days.
“We’ve developed a screening methodology to basically look back in time in people’s [blood] sera and see what they have experienced,” said Dr Stephen Elledge from Harvard Medical School, who led the development team.
“Instead of testing for one individual virus at a time, which is labour intensive, we can assay all these at once. It’s one-stop shopping,” he said.
The Latest on: Blood Test
via Google News
The Latest on: Blood Test
- Vitalant Blood drive planned at Sunland Park Mall; free COVID-19 antibody test providedon January 20, 2021 at 1:10 pm
Vitalant Blood Service will have a blood drive from 2 to 6 p.m. Jan. 22 at Sunland Park Mall. Donors will receive a complimentary COVID-19 antibody test as part of their donation, in addition to the ...
- A Common Blood Oxygen Test Fails to Detect the Worst Effects of COVID-19 in Many Black Patientson January 20, 2021 at 5:51 am
Michael Sjoding, a pulmonary physician and professor based in Michigan and originally from Salem, Ore., conducted a study on the device.
- Blood test could bring new hope to Alzheimer's clinical trialson January 19, 2021 at 6:14 am
A team of scientists at UCL have found that blood tests measuring the hallmark Alzheimer's protein, b-amyloid (amyloid), could radically reduce the cost of clinical trials and potentially open the ...
- Rapid blood test identifies COVID-19 patients at high risk of severe diseaseon January 18, 2021 at 12:48 pm
Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe ...
- Simple blood test can predict which COVID-19 patients are at high risk of severe diseaseon January 17, 2021 at 4:18 pm
One of the most vexing aspects of the COVID-19 pandemic is doctors' inability to predict which newly hospitalized patients will go on to develop severe disease, including complications that require ...
- New studies support blood test for early detection of Alzheimer's diseaseon January 16, 2021 at 10:32 pm
Researchers provide convincing evidence that an in-house developed blood test for Alzheimer's disease can detect the disease early and track its course, which has major implications for a potential ...
- FDA Clears First Rapid Handheld Blood Test for Concussionon January 14, 2021 at 10:46 am
The US Food and Drug Administration (FDA) has approved the first rapid handheld blood test for suspected mild traumatic brain injury (TBI), the company has announced. The test yields results within 15 ...
- Researchers demonstrate great potential for blood test to detect, monitor Alzheimer's diseaseon January 14, 2021 at 9:08 am
In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for ...
- Blood test shows promise for early detection of acute heart transplant rejectionon January 13, 2021 at 7:36 am
Researchers have developed a blood test that could make it possible for doctors to detect—then quickly prevent or slow down—acute heart transplant rejection, a potentially deadly condition that occurs ...
- Blood Test May Help Diagnose Alzheimer's Disease, Scientists Sayon January 12, 2021 at 8:20 pm
A simple blood test may soon be available so that doctors can diagnose patients with two common forms of dementia – Alzheimer's disease and frontotemporal dementia (FTD) ...
via Bing News